For those who like to track the performance of the FDA some new metrics have just arrived Last year the agency approved  novel new medicines or new molecular entities in industry parlance This amounted to  of the  marketing applications that were received Although not all applications submitted in  had been accepted as of the end of the calendar year the agency estimated that the final tally would amount to  applications based on prior experience While  may seem robust the results trail  when the FDA approved  of  novel new medicines